Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

Anthem Blue Cross Blue Shield and Memorial Sloan Kettering Cancer Center have reached a deal that keeps the premiere cancer ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in New York and Memorial Sloan Kettering Cancer Center (MSK) announced today that the organizations have reached a new multi-year ...

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

The Brian and Sheila Jellison Family Foundation is proud to be the first major donor to support Cancer Vaccine Coalition (CVC ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...